https://clinicaltrials.gov/ct2/show/NCT03570359?type=Intr&cond=COPD&phase=01234&lupd_s=12%2F17%2F2018&lupd_d=14&sort=nwst A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza Condition : Chronic Obstructive Pulmonary Disease (COPD) Interventions : Drug: Interferon Beta-1A; Other: Placebo Sponsor : Synairgen Research Ltd. Recruiting NCT03570359 Wed, 27 Jun 2018 12:00:00 EDT
Synairgen
Synairgen Developing COPD Treatment To Hold Off Further Viral Damage
https://scrip.pharmaintelligence.informa.com/SC124368/Synairgen-Developing-COPD-Treatment-To-Hold-Off-Further-Viral-Damage Synairgen Developing COPD Treatment To Hold Off Further Viral Damage
